Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib versus placebo for platelet transfusion-dependent MDS or CMML
2004-004685-32Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) comparing Lonafarnib with Placebo (2 arms). Started Jul 2005; status: terminated.
02
Drugs
lonafarnib
03
Conditions
myelodysplastic syndrome (MDS)chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on 2004-004685-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004685-32.